Global Scans · Healthtech · Weekly Summary

• [New] By application, the rare & genetic diseases segment is expanding at a significant CAGR between 2026 and 2035. Precedence Research
• [New] By ensuring that prescribed drugs align with an individual's genetic profile, personalized medicine may decrease trial-and-error prescribing, lower adverse events, and ultimately help control escalating pharmacy costs projected to increase by over 10% in 2026. eclipsewellness.net
• [New] The branded originator molecules and next-generational anti-VEGFs-like faricimab (Vabysmo; Genentech) and aflibercept - will still be in great shape throughout 2026 and beyond given their efficacy, durability, and long-standing safety record. Ophthalmology Times - Clinical Insights for Eye Special
• [New] In light of the IND clearance, GenEditBio plans to launch a phase 1/2 clinical trial entitled CLARITY, with enrolment activities expected to begin in the second quarter of 2026. CGTlive
• [New] Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. EurekAlert!
• [New] The genetic bottleneck in U.S. honey bee populations poses long-term sustainability risks. My Site
• [New] The biggest vertical integration plays in 2026 will be in technology, specialty care and pharmacy as insurers like Cigna and Elevance continue building out their lucrative health services divisions. Healthcare Dive
• [New] Megabrands will take advantage of the challenging environment to snap up smaller regional plans, technology and pharmacy assets, and physician practices, even as worries mount about shrinking competition in the U.S. healthcare sector. Healthcare Dive
• [New] We expect 2026 to bring a continued focus on transitioning from digital health and other technology-centric innovation to therapeutics and diagnostics. Passle
• [New] In 2026, e-discovery tools-augmented with generative AI-will be core to breach response, enabling teams to rapidly analyze exposed data, assess risk, and support notification and remediation efforts with familiar platforms and workflows. Relativity
• [New] The Australian Government is leading the way in turning the game-changing potential of genomics into improved prevention, risk-reduction, early detection, treatment and outcomes of cancer. Mirage News
• [New] The Australian Government has today opened for public consultation a draft policy framework that will strengthen genomics-informed cancer care for all Australians. Mirage News
• [New] Japan will generate significant revenue through the overseas expansion of fully closed and controlled plant factories and land-based aquaculture facilities, where Japanese startups boast world-class technologies. Prime Minister's Office of Japan
• [New] India has a once-in-a-generation opportunity to lead the global shift towards ethical, lab-grown diamonds. The Times Of India
• [New] The Israel Meteorological Service is using Earth-2 CorrDiff in operation - and plans to use Earth-2 Nowcasting - to generate high-resolution forecasts up to eight times daily, enabling decision-makers to respond more effectively to extreme weather while reducing computational costs. NVIDIA Blog
• [New] Just weeks after first deliveries of the next generation Chevrolet Bolt electric vehicle (EV) began, General Motors has confirmed it will discontinue production of it in mid-2027. Automotive World
• [New] The Trump administration believes it will be able to unlock next-generation breakthroughs through deregulation, tax cuts, abundant energy, and efforts to attract significant inbound investment. Brookings
• [New] By 2026, around 60% of organizations worldwide will run internal generative AI platforms. Cherriemoraga.com
• [New] In 2026, genetic testing will be common, and treatments will become more customized. Pinnacle Lifescience
• [New] In 2026, investment in women's health will expand rapidly as technology focuses on filling longstanding gaps in areas such as menopause, autoimmune conditions, metabolic and cognitive health, and more. Healthcare IT Today | Fresh, Daily, Practical Healthcar
• [New] The focus for 2026 has shifted toward epigenetic therapy-modifying gene expression without the risks of off-target DNA cleavage associated with traditional CRISPR. GeneOnline News

Last updated: 01 February 2026